CN101700390B - Oral traditional Chinese medicine composition for treating fatty liver - Google Patents
Oral traditional Chinese medicine composition for treating fatty liver Download PDFInfo
- Publication number
- CN101700390B CN101700390B CN2009102301197A CN200910230119A CN101700390B CN 101700390 B CN101700390 B CN 101700390B CN 2009102301197 A CN2009102301197 A CN 2009102301197A CN 200910230119 A CN200910230119 A CN 200910230119A CN 101700390 B CN101700390 B CN 101700390B
- Authority
- CN
- China
- Prior art keywords
- grams
- fatty liver
- chinese medicine
- rhizoma
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 32
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 31
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 31
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 241000218176 Corydalis Species 0.000 claims abstract description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 13
- 230000002411 adverse Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 241000748223 Alisma Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 25
- 210000004369 blood Anatomy 0.000 description 25
- 210000004185 liver Anatomy 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 210000000481 breast Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000208365 Celastraceae Species 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 235000000336 Solanum dulcamara Nutrition 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical class O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses oral traditional Chinese medicine composition for treating fatty liver, belonging to the field of the traditional Chinese medicine. The oral traditional Chinese medicine composition for treating fatty liver is characterized by comprising the following raw Chinese herbal medicine by weight: 10 grams of curcuma, 15 grams of white atractylodes rhizome, 10 grams of cassia seeds, 10 grams of Chinese angelica, 10 grams of magnolia officinalis, 10 grams of rhizoma atractylodis, 10 grams of green orange peel, 10 grams of rhubarb, 15 grams of morinda officinalis, 15 grams of polygonum cuspidatum, 15 grams of pinellia, 20 grams of poria, 20 grams of alisma, 30 grams of salvia, 6 grams of rhizoma corydalis and 6 grams of licorice. The oral traditional Chinese medicine composition can take effect quickly and treat the fatty liver easily, has short course of fatty liver treatment and low cost, can not cause any side effect and adverse effect to the health of the patient andis clinically proved of having high curative rate.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of orally taken for curing fatty liver, belong to the field of Chinese medicines.
Background technology
Fatty liver is meant the interior too much a kind of pathological state of lipopexia of hepatocyte that liver itself and the outer reason of liver cause, if the fat content of accumulating surpasses 5% of liver weight in wet base, or 50% above hepatocyte fatization is arranged on the histology, promptly is called fatty liver.
Forming the main cause of fatty liver, is because due to increase of hepatocyte lipogenesis or the oxidation minimizing.Clinical research finds that increasing of pathogenesis of fatty liver rate has substantial connection with the raising of people's living standard and the change of dietary structure.Light-duty fatty liver can be without any symptom, has only that ultrasonic or CT examination etc. just is found by Type B.After fatty liver forms, most of performance inappetence, feel sick, vomiting, weight loss, weak, abdominal distention, uncomfortable liver area or dull pain, the liver cirrhosis performance can appear in critically ill patient.
For the still to no effect significant specific treatment of the present doctor trained in Western medicine of this disease, the blood fat reducing therapy is mainly adopted in the clinical treatment to fatty liver of doctor trained in Western medicine, because the lipid in the blood lipid-lowering medicine promotion blood is to the liver transportation and carry out the metabolism drainage, and fatty liver is often with the liver lipidosis, so fat-reducing medicament is many to the toxic effect of liver.Confirm through a large amount of clinical experiments, Chinese medicine can promote the reverse of fatty liver and improve clinical symptoms, the whole determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs of Chinese medicine, toxic and side effects is significantly reduced, and solved the toxic and side effects of taking Western medicine for a long time and being brought, all types of cureless Patients with Fatty Liver all there is significant curative effect.
Summary of the invention
In order to overcome the shortcoming that above-mentioned prior art exists, the invention provides a kind of Chinese medicine composition of orally taken for curing fatty liver.
Technical scheme of the present invention is: a kind of Chinese medicine composition of orally taken for curing fatty liver, it is characterized in that, make: Radix Curcumae 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Semen Cassiae 10 grams, Radix Angelicae Sinensis 10 grams, Cortex Magnoliae Officinalis 10 grams, Rhizoma Atractylodis 10 grams, Pericarpium Citri Reticulatae Viride 10 grams, Radix Et Rhizoma Rhei 10 grams, Radix Morindae Officinalis 15 grams, Rhizoma Polygoni Cuspidati 15 grams, the Rhizoma Pinelliae 15 grams, Poria 20 grams, Rhizoma Alismatis 20 grams, Radix Salviae Miltiorrhizae 30 grams, Rhizoma Corydalis 6 grams, Radix Glycyrrhizae 6 grams by the crude drug of following weight.
Preparation and instructions of taking: crude drug is mixed in the marmite, and it is saturating to add blister; Elder generation's intense fire is fried boiling, and with half an hour at a simmer, leaches medicinal liquid again, adds water in the medicinal residues and fries in shallow oil half an hour, leaches medicinal liquid again.Twice medicinal liquid mixed, cools completely,, took in two hours after the supper respectively at half an hour ante cibum morning.15 days is a course of treatment.
Pharmacological action:
1) Radix Curcumae: arduous, cold.Go into the heart, lung, Liver Channel.Promoting QI circulation for relieving depression, the removing heat from blood removing blood stasis with potent drugs is controlled all pains of breast abdomen side of body rib, and it is demented to lose the heart, the calentura coma. spit blood jaundice.
2) Rhizoma Atractylodis Macrocephalae: bitter sweet, temperature.Go into spleen, stomach warp.Spleen reinforcing, stomach reinforcing, dampness and in, antiabortive.Control deficient QI of the spleen and stomach, anorexia, the asthenia weak breath, deficiency-distension is had loose bowels, phlegm retention, edema, jaundice, arthralgia chiefly caused by damp pathogen, dysuria, dizziness, spontaneous perspiration, nausea uneasiness.
3) Semen Cassiae: bitter sweet, cold.Go into liver, kidney channel.Liver heat removing arranged, make eye bright, dispel the wind, the effect of relieving constipation.Control the puckery pain of conjunctival congestion, the many tears of photophobia, it is dizzy to have a headache, poor vision, constipation.
4) Radix Angelicae Sinensis: Gan Xin, temperature.Go into the heart, liver, spleen channel.Benefiting blood and regulating blood circulation, menstruction regulating and pain relieving is moisturized laxation.Control menoxenia, amenorrhea stomachache ， mass in the abdomen knot is poly-, metrorrhagia; Headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome; The dryness of the intestine dyschezia is heavy after the bloody dysentery; The carbuncle skin ulcer is stolen, injury from falling down.
5) Cortex Magnoliae Officinalis: warming middle-JIAO, the therapeutic method to keep the adverse QI flowing downwards, dampness, expectorant.Control breast abdomen feeling of fullness distending pain, regurgitation, vomiting, dyspepsia does not disappear, and phlegm retention is breathed with cough, the cold-damp dysentery.
6) Rhizoma Atractylodis: arduous, temperature.Go into spleen, stomach warp.Spleen invigorating, dampness, resolving depression is warded off dirty.Control wet the Sheng and be stranded spleen, the asthenia drowsiness, gastral cavity painful abdominal mass abdominal distention, inappetence, vomiting is had loose bowels, dysentery, malaria, phlegm retention, edema, seasonal epidemic pathogens flu, anemofrigid-damp arthralgia, flaccidity of the lower limbs, nyctalopia.
7) Pericarpium Citri Reticulatae Viride: temperature, acrid in the mouth.Go into liver, gallbladder meridian.Soothing the liver dispelling the stagnated QI, the eliminating stagnation expectorant.Control breast side of body gastralgia, hernia, food stagnation, swelling of the breast, nodule in the breast, chronic malaria addiction piece.
8) Radix Et Rhizoma Rhei: bitter in the mouth, cold.Go into stomach, large intestine, Liver Channel.Purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation.The poison that purges heat, removing mass stagnates, clots absorbing blood.Control the excess-heat constipation, delirium is sent out holder, the food stagnation feeling of fullness, dysentery is from the beginning of, tenesmus, stasis of blood menolipsis Bi ， lumps in the chest and abdomen, the time row epidemic disease due to heat pathogen, sudden and violent swelling ophthalmalgia is spitted blood, epistaxis, YANG jaundice, edema, stranguria with turbid discharge is also urinated, carbuncle and ulcer toxic swelling, furuncle, burn.
9) Radix Morindae Officinalis: Xin Gan, temperature.Go into liver, kidney channel.Kidney-replenishing, strengthening bone and muscle, wind-damp dispelling.Control sexual impotence, few abdomen cold type of pain, incontinence of urine, deficiency-cold of uterus, anemofrigid-damp arthralgia, soreness of waist and knee joint.
10) Rhizoma Polygoni Cuspidati: hardship, cold, return liver, lung, gallbladder meridian.Heat-clearing and toxic substances removing, promoting blood circulation and stopping pain, dampness removing jaundice eliminating, relieving cough and asthma.This product bitter cold is fallen and is let out, and merit is arrogated to oneself removing damp-heat from the liver and the gallbladder, again can the promoting blood circulation to restore menstrual flow pain relieving.
11) Rhizoma Pinelliae: dampness is through expectorant, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.Control the damp-phlegm cold drink, vomiting regurgitation, syncope due to accumulation of phlegm headache, dizzy sleeplessness.
12) Poria: sweet light, flat.Go into the heart, spleen, lung meridian.Eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.Control dysuria, the edema distension, the phlegm retention cough with dyspnea, the sound of vomiting of vomitting is had loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful.
13) Rhizoma Alismatis: sweet, cold.Go into kidney, urinary bladder channel.Diuretic, eliminating dampness by diuresis expels the heat-evil.Control dysuria, edema distension, vomiting, dysentery, phlegm retention, beriberi, gonorrhea, hematuria.
14) Radix Salviae Miltiorrhizae: hardship is slightly cold; GUIXIN, Liver Channel.Activating blood circulation to dissipate blood stasis, the removing heat from blood mind calming.This product is fallen and promoting the circulation of blood, is apt to into blood system, can qualcomm meridian, change stasis, clearing away heart-fire, removing heat from blood heat, and the will of calming the nerves, remove and throb with fear tiredly, be usually used in obstruction of qi in the chest and cardialgia, menstruation portion transfers, skin infection swells and ache, insomnia and congestion disease such as swell and ache.
15) Rhizoma Corydalis: hot, bitter, temperature is returned liver, the heart, and the stomach warp, activating blood circulation to dissipate blood stasis, promoting the circulation of QI to relieve pain are apt to control inside and outside all pains, are widely used in obstruction of qi in the chest and cardialgia, stomachache due to hyperactive liver-QI attacking the stomach, dysmenorrhea, gather stomachache, treating swelling and pain by traumatic injury, bones and muscles pain.Studies confirm that: this product contains compositions such as tetrahydropalmatine, has calmness, analgesic activity.
16) Radix Curcumae: arduous, cold.Go into the heart, lung, Liver Channel.Promoting QI circulation for relieving depression, the removing heat from blood removing blood stasis with potent drugs is controlled all pains of breast abdomen side of body rib, and it is demented to lose the heart, the calentura coma. spit blood jaundice.
17) Radix Glycyrrhizae: sweet, flat.GUIXIN, lung, spleen, stomach warp.Invigorating the spleen and replenishing QI is grown and to be coughed lung moistening, and the emergency detoxifcation is in harmonious proportion hundred medicines.Cure mainly laryngopharynx swelling and pain, cellulitis skin infection, gastrointestinal ulceration and separate poison of drug, alimentary toxicosis etc.The Radix Glycyrrhizae agent has the function of antiinflammatory and resistance attitude reflection, therefore in doctor trained in Western medicine clinically mainly as demulcent.Enoxolone has the effect of desoxycortone class, and chronic adrenocortical insufficiency is had good efficacy.The flavone of Radix Glycyrrhizae has antiinflammatory, spasmolytic and antiacid effect.
The present invention is with after the said medicine combination, and its drug effect has synergism, have circulation of qi promoting and in, the effect of turbid, the blood circulation promoting and blood stasis dispelling of dispersing the stagnated live-QI to relieve the stagnation of QI, damp eliminatingization.The Chinese medicine mixture of this kind orally taken for curing fatty liver has instant effect in treatment aspect the fatty liver, and medical expense is low, can advantages such as any adverse effect not arranged to patient's health, and is higher through the clinical verification cure rate.
After the present invention adopts above prescription, have following clinical effectiveness:
1. effectively alleviate: 60 examples are observed in treatment, treated 10 days, and 52 examples of fully recovering (86.67%), produce effects 8 examples (13.33%), invalid 2 examples (3.33%), total effective rate is up to 96.67%.
2. effectively improve clinical symptoms, improve patient's life quality: general patient took medicine 2 days, and weak, uncomfortable liver area obviously alleviates, and felt sick, symptom such as inappetence improves.
3. pure Chinese medicinal preparation has no adverse reaction.General patient's medication one or two of symptom disappears course of treatment substantially, and can thoroughly fully recover for three to four courses of treatment.
Model case
Example 1, Zhao Zhihui, man, 55 years old, people from Zhejiang.Patient's uncomfortable liver area, conscious weak, feel sick the xerostomia halitosis.Remove examination in hospital: fatty liver (moderate), the chemical examination liver function is found: the transaminase increases, and bilirubin is normal; Blood fat raises, and is diagnosed as: obese fatty liver.Through taking Chinese medicine composition that the present invention treats fatty liver after two courses of treatment, transference cure, body weight obviously descends, and the blood fat check is normal, and it is normal to look into liver function, and has taken a course of treatment, thoroughly rehabilitation.
Example 2, Wang Chenggang, man 46 years old, people from Jiangsu.Be addicted to drink on ordinary days, the immediate cause body weight constantly increases, and through chemically examining liver function: the transaminase increases, and bilirubin is normal; B ultrasonic shows: fatty liver severe.Be diagnosed as: alcoholic fatty liver.The Chinese medicine composition of taking this kind treatment fatty liver is after two courses of treatment, and B ultrasonic shows: fatty liver is slight, after take two courses of treatment again, its alcohol prohibition is advised in the transference cure drug withdrawal, periodic review, thoroughly rehabilitation at present.
Example 3, Yu Haiyang, man 48 years old feels uncomfortable in chest, fatigue and weak recently, abdominal distention, hepatalgia, B ultrasonic shows: " specific fat liver waveform " liver increases, and is diagnosed as fatty liver.After taking we treatment course of treatment, the patient feels well, hepatalgia, transference cure such as uncomfortable in chest, unable.
Example 4, Xu Sumei, woman, obesity, recent panesthesia fatigue and weak, right chest pain.Fatty liver (moderate) is found in health check-up, and through taking medicine of the present invention after 1 course of treatment, chest pain disappears, and continues again to take medicine 2 courses of treatment, transference cure, it is normal to look into liver function, continue to strengthen the treatment three months after B ultrasonic show: fatty liver is slight, advises its drug withdrawal, balanced diet, appropriate exercise, periodic review.
The specific embodiment
Embodiment one:
Prescription: Radix Curcumae 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Semen Cassiae 10 grams, Radix Angelicae Sinensis 10 grams, Cortex Magnoliae Officinalis 10 grams, Rhizoma Atractylodis 10 grams, Pericarpium Citri Reticulatae Viride 10 grams, Radix Et Rhizoma Rhei 10 grams, Radix Morindae Officinalis 15 grams, Rhizoma Polygoni Cuspidati 15 grams, the Rhizoma Pinelliae 15 grams, Poria 20 grams, Rhizoma Alismatis 20 grams, Radix Salviae Miltiorrhizae 30 grams, Rhizoma Corydalis 6 grams, Radix Glycyrrhizae 6 grams.
Preparation and instructions of taking: crude drug is mixed in the marmite, and it is saturating to add blister; Elder generation's intense fire is fried boiling, and with half an hour at a simmer, leaches medicinal liquid again, adds water in the medicinal residues and fries in shallow oil half an hour, leaches medicinal liquid again.Twice medicinal liquid mixed, cools completely,, took in two hours after the supper respectively at half an hour ante cibum morning.15 days is a course of treatment.
Claims (1)
1. the Chinese medicine composition of an orally taken for curing fatty liver, it is characterized in that, make: Radix Curcumae 10 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, Semen Cassiae 10 grams, Radix Angelicae Sinensis 10 grams, Cortex Magnoliae Officinalis 10 grams, Rhizoma Atractylodis 10 grams, Pericarpium Citri Reticulatae Viride 10 grams, Radix Et Rhizoma Rhei 10 grams, Radix Morindae Officinalis 15 grams, Rhizoma Polygoni Cuspidati 15 grams, the Rhizoma Pinelliae 15 grams, Poria 20 grams, Rhizoma Alismatis 20 grams, Radix Salviae Miltiorrhizae 30 grams, Rhizoma Corydalis 6 grams, Radix Glycyrrhizae 6 grams by the crude drug of following weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102301197A CN101700390B (en) | 2009-11-16 | 2009-11-16 | Oral traditional Chinese medicine composition for treating fatty liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102301197A CN101700390B (en) | 2009-11-16 | 2009-11-16 | Oral traditional Chinese medicine composition for treating fatty liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101700390A CN101700390A (en) | 2010-05-05 |
| CN101700390B true CN101700390B (en) | 2011-08-17 |
Family
ID=42155334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102301197A Expired - Fee Related CN101700390B (en) | 2009-11-16 | 2009-11-16 | Oral traditional Chinese medicine composition for treating fatty liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101700390B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105194632A (en) * | 2015-10-29 | 2015-12-30 | 蒋玉群 | Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease |
| CN105535826A (en) * | 2015-12-29 | 2016-05-04 | 上海珍岛信息技术有限公司 | Pharmaceutical composition for treating cat fatty liver and preparation method thereof |
| CN108653660A (en) * | 2018-07-26 | 2018-10-16 | 谢良才 | A kind of drug for treating alcoholic liver, fatty liver |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015668A (en) * | 2007-01-16 | 2007-08-15 | 李卓伦 | Fatty liver treating medicine |
| CN101401920A (en) * | 2008-11-06 | 2009-04-08 | 张晨 | Traditional Chinese medicine preparation for treating fatty liver |
-
2009
- 2009-11-16 CN CN2009102301197A patent/CN101700390B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015668A (en) * | 2007-01-16 | 2007-08-15 | 李卓伦 | Fatty liver treating medicine |
| CN101401920A (en) * | 2008-11-06 | 2009-04-08 | 张晨 | Traditional Chinese medicine preparation for treating fatty liver |
Non-Patent Citations (4)
| Title |
|---|
| 张太坤等.中医药治疗脂肪肝的研究现状.《甘肃中医》.2006,第19卷(第04期),40-42. * |
| 张琪.中医药治疗脂肪肝近况.《广西中医药》.2000,第23卷(第05期),58-60. * |
| 汤志顺.近3年中医药治疗脂肪肝进展.《安徽中医临床杂志》.2002,第14卷(第01期),66-67. * |
| 钟燕春.中医药治疗脂肪肝进展.《辽宁中医药大学学报》.2008,第10卷(第2期),64-65. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101700390A (en) | 2010-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1321680C (en) | Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer | |
| CN101401920B (en) | Traditional Chinese medicine preparation for treating fatty liver | |
| CN102319412B (en) | Traditional Chinese medicine used for treating diarrhea | |
| CN102526616B (en) | Chinese medicinal herb pills for treating cholecystitis and gallstone | |
| CN103341064B (en) | Chinese medicine composition for treating urine retention | |
| CN103071023B (en) | Traditional Chinese medicinal composition for effectively treating diabetes | |
| CN101401925A (en) | Traditional Chinese medicine decoction for treating fatty liver | |
| CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN104940784A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104225215A (en) | Traditional Chinese medicine for treating insomnia | |
| CN100579562C (en) | Oral Chinese medicine composition for treating constipation | |
| CN102526670A (en) | Traditional Chinese medicinal composition for treating cholecystitis and preparation method thereof | |
| CN101700390B (en) | Oral traditional Chinese medicine composition for treating fatty liver | |
| CN103212020B (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN102430105A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104383268A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN104306929A (en) | Traditional Chinese medicine formula for treating severe acute pancreatitis and preparation method of traditional Chinese medicine formula | |
| CN104740288A (en) | Traditional Chinese medicine composition for treating constipation | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN103006980A (en) | Chinese medicinal composition for treating distention and fullness | |
| CN101703740B (en) | Chinese medicinal preparation for treating fatty liver | |
| CN102600424A (en) | Chinese herba preparation for treating nephropyelitis and preparation method of Chinese herba preparation | |
| CN102579633B (en) | Traditional Chinese medicine composition for curing vital energy deficiency type postpartum lochiorrhea and preparation method thereof | |
| CN104352803A (en) | Traditional Chinese medicinal preparation for treating stomach cancer | |
| CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: YANG SILIAN Free format text: FORMER OWNER: ZHENG HAIBO Effective date: 20110617 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yang Silian Inventor before: Zheng Haibo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHENG HAIBO TO: YANG SILIAN Free format text: CORRECT: ADDRESS; FROM: 250014 NO. 53, JINGSHI ROAD, LIXIA DISTRICT, JI NAN CITY, SHANDONG PROVINCETO: 252000 LIAOCHENG NO. 3 PEOPLE S HOSPITAL, NO. 62, WEIYU ROAD, LIAOCHENG CITY, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20110617 Address after: 252000 Shandong city of Liaocheng province Wei Yuk Road No. 62 Liaocheng Third People's Hospital Applicant after: Yang Silian Address before: 250014, No. ten, No. 53, Lixia District, Ji'nan City, Shandong Province Applicant before: Zheng Haibo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110817 Termination date: 20111116 |